Bristol v. Davol, Inc. and C.R. Bard, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Bristol v. Davol, Inc. and C.R. Bard, Inc.

Sort by

Viewing results 1‒20 of 20

Equities
Markets Now - Monday 8th June 2020
...GILD’s c$15bn cost base vs $11bn core op.income, of which c$5bn lies in R&D/SG&A), but also require very significant job cuts at a time of global economic hardship....
June 8, 2020
LexUS & Canadian companies
Meg Whitman: talk the line Premium content
...Others end, to borrow a song from Ms Whitman’s favourite musical genre, in “D-I-V-O-R-C-E”. The Lex team is interested in hearing more from readers. Has Meg Whitman finished her work at HPE?...
August 29, 2017
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
News in-depthCompanies By Region
Drugmakers premiere summer blockbusters
...The first of these so-called immunotherapies was launched by Merck and Bristol-Myers Squibb last year and analysts expect them to generate $35bn of annual sales within a decade....
July 12, 2015
News in-depthThe Big Read
Biotech: Making sense of the science
...R & D failures....
April 13, 2015
Lucy Kellaway
Google CFO Pichette’s ‘I quit’ note is a classic in a dodgy genre
...Patrick and Tamar haven’t seen a great deal of each other in the past 25 years; one hopes that the playlist that accompanies their future trek is more Africa than D.I.V.O.R.C.E....
March 15, 2015
The Big Read
Healthcare: Counting the cost of cancer
...The answer, he argues, is to break up inefficient R&D operations and outsource innovation to nimbler biotech companies — a prescription big pharma is already embracing....
January 15, 2015
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
US & Canadian companies
Bristol-Myers Squibb could realise $6bn from diabetes franchise
...His calculations were triggered by comments from BMS late on Thursday that it was scaling back discovery work on diabetes, as well as hepatitis C and neuroscience, in order to focus on speciality therapies...
November 8, 2013
beyondbricsMarkets
Brookings comes to India
...Dattaraj V. Salgaocar (V. M. Salgaocar Group) Harsh Pati Singhania (J.K. Organisation) Krishen Sud (Sivik Global Healthcare, Inc.)...
January 30, 2013
US healthcare reform
Illumina adopts ‘poison pill’ against Roche
...Bristol-Myers Squibb, which faces losing patent protection on several top-selling drugs, followed suit in January agreeing to buy Inhibitex for $2.5bn, another developer of new treatments for hepatitis C...
January 26, 2012
Investments
Big pharma tipped as tonic for investors
...In early January, Bristol-Myers Squibb agreed to pay $26 a share to gain control of hepatitis C drug developer Inhibitex – a 163 per cent premium to its share price before the deal....
February 3, 2012
FT AlphavilleJoseph Cotterill
Citi, Credit Suisse settle SEC CDO probe
...“Investors were not informed that Citgroup had decided to bet against them and had helped choose the assets that would determine who won or lost.” Kenneth R....
October 19, 2011
US & Canadian companies
Valeant’s Cephalon bid portends new era
...He highlights a dozen potential targets that have high free cash flows relative to market capitalisation, including Impax, Eli Lilly, Cubist and Bristol-Myers Squibb....
April 4, 2011
FT PeopleUK companies
Wedding fever in the City
...Finally, Mr O’Connor could not resist heading his note on the departure of Paul Stobart, Sage’s northern European chief executive, as D.I.V.O.R.C.E....
April 28, 2011
FT AlphavilleCardiff Garcia
Insider trading frat dorks
...An announcement from the SEC on Wednesday, emphasis (and a bit of chuckling) ours: Washington, D.C., Dec. 8, 2010 — The Securities and Exchange Commission today charged a Baltimore-based business consultant...
December 8, 2010
FT AlphavilleStacy-Marie Ishmael
Greenberg’s CV Starr says it’s only poached 13 AIG employees
...Emphasis ours: There have been a number of recent reports about an exodus of employees from A.I.G., and the role of C.V. Starr & Co., Inc....
October 27, 2009
FT Live
Crypto and Digital Assets Summit Asia
Transforming mainstream finance
Thursday, 5 DecemberSingapore
US & Canadian companies
Southwestern’s Korell is industry’s best-value chief
...He remembers uncapping a black marker to write: R squared over A is V+, in what he calls a type of epiphany....
November 29, 2009
Global Economy
It is in America’s interest to save AIG
...The writer is chairman and chief executive officer of C.V. Starr....
September 16, 2008
Mergers & Acquisitions
Signatories: ICC letter on the Doha Round to the editor of the Financial Times
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
February 28, 2007
Technology sector
Gadget Guru: RSSed out
...John C Katzendorn A. Most new LCD TVs (including the BenQ and Dell models) also provide standard inputs for PCs so you can plug your laptop into the TV and switch from TV mode to PC mode easily....
May 31, 2006
Phone hacking
The ads that proved themselves
...V is for virgin, judged best new client for Virgin Mobile, Virgin Trains and Virgin Mobile Australia. W is for why not?...
November 2, 2004

Previous pagePage 1 of 1Next page